IP Library › Granted Patent US 9,701,947
Granted Patent B2
US 9,701,947 · App. 13/551,605 · Granted Jul 11, 2017

Fatty acid desaturases from primula

Inventors: Virginia Ursin (Pawcatuck, CT); Byron Froman (Davis, CA); Jennifer Simmons (Woodland, CA); Thomas J. LaRosa (Fenton, MO); Fenggao Dong (Chesterfield, MO); Steven Screen (St. Louis, MO)
Assignee: Monsanto Technology LLC
C12N9/0004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,701,947
App. No.
13/551,605
Granted
Jul 11, 2017
Kind
B2
Abstract

The invention relates generally to methods and compositions concerning desaturase enzymes that modulate the number and location of double bonds in long chain poly-unsaturated fatty acids (LC-PUFA's). In particular, the invention relates to methods and compositions for improving omega-3 fatty acid profiles in plant products and parts using desaturase enzymes and nucleic acids encoding for such enzymes. In particular embodiments, the desaturase enzymes are Primula Δ6-desaturases. Also provided are improved soybean oil compositions having SDA and a beneficial overall content of omega-3 fatty acids relative to omega-6 fatty acids.

Claims (13)

1. A lotion or ointment for topical application comprising an endogenous soybean oil that endogenously comprises stearidonic acid (SDA) and gamma linolenic acid (GLA) in a ratio of at least about 1.3.

2. The lotion or ointment of claim 1 wherein said endogenous soybean oil comprises at least about 0.1% SDA.

3. The lotion or ointment of claim 1 wherein said ratio of SDA/GLA is at least about 1.5.

4. The lotion or ointment of claim 1 wherein said ratio of SDA/GLA is at least about 2.0.

5. The lotion or ointment of claim 1 wherein said ratio of SDA/GLA is at least about 2.5.

6. The lotion or ointment of claim 1 wherein said ratio of SDA/GLA is at least about 3.0.

7. The lotion or ointment of claim 1 wherein said oil further comprises alpha-linolenic acid (ALA).

8. The lotion or ointment of claim 7 further comprising a ratio of SDA/ALA wherein said ratio of SDA/ALA is at least about 0.5.

9. The lotion or ointment of claim 8 wherein said ratio of SDA/ALA is at least about 1.0.

10. The lotion or ointment of claim 8 wherein said ratio of SDA/ALA is at least about 1.5.

11. The lotion or ointment of claim 8 wherein said ratio of SDA/ALA is less than about 1.8.

12. The lotion or ointment of claim 1 wherein said lotion or ointment further comprises an excipient.

13. The lotion or ointment of claim 1 wherein said SDA comprises SDA in a form selected from the group consisting of conjugated forms, esters, amides, sodium salts, potassium salts, lithium salts, N-alkylpolyhydroxamine salts, N-methyl glucamine, and ethyl esters.

Continuity (4)
Division 11891426 · Jun 12, 2008
Continuation 10569387
Provisional Application 60496751 · Aug 21, 2003
Related Publication 20130041032A1 · Feb 14, 2013